Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides. These proprietary drug candidates are uniquely engineered, stable, macrocyclic peptides with very low immunogenicity and favorable safety profile. They modulate pathologic inflammatory diseases and hold the ability to restore the immune homeostasis.
Company Details
- Founded
- -
- Address
- California, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://oryntherapeutics.com
- Keywords
- San Francisco.
- HQ
- California
Oryn Therapeutics Questions
Oryn Therapeutics's website is http://oryntherapeutics.com
Oryn Therapeutics's LinkedIn profile is https://www.linkedin.com/company/oryn-therapeutics
Oryn Therapeutics's industry is
Biotechnology Research
Oryn Therapeutics's top competitors are
Biomarin Pharmaceutical Inc.,
Capricor Therapeutics, Inc.,
Iconovir Bio,
Gossamer Bio,
Therini Bio, Inc.,
Kala Bio,
Siren Biotechnology,
Acmp Clinical And Regulatory Consulting Llc,
Ibio, Inc.,
Anglepoint.
Oryn Therapeutics's categories are Biotechnology Research
Oryn Therapeutics's founding year is 2022
